StreetAlpha
13F holdings · Q3 2026

Palo Alto Investors

Palo Alto, CA · files as Palo Alto Investors LP
Know the moment Palo Alto Investors filesYou follow Palo Alto Investors An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Filed
Holdings as of Sep 30, 2026Filed Nov 16, 2026Next filing due Feb 15, 2027CIK 1306923

Palo Alto Investors reported 56 stocks worth $672M in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are PTCT (8.4%), IOVA (7.7%) and INSM (7.5%). Compared with Q2 2026, the fund opened new positions in TARA, CTNM and ANL, added to INSM, MIRM and DYN and trimmed PTCT, IOVA and ACAD.

Latest filing: what Palo Alto Investors did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
4 new10 added25 trimmed0 sold outBought about $36.4M · sold about $67.3M
New 4
Added 10
See all 10 →
Trimmed 25
See all 25 →
Sold out 0

None

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$672M−7.1% vs last quarter
Stocks held564 new · 0 sold out
Top 5 weight36.8%fairly concentrated
Turnover15%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
PTCT
Ptc Therapeutics Inc
$56.7M8.4%875K−43K (−5%)8 of 8
2
IOVA
Iovance Biotherapeutics Inc
$51.4M7.7%3.5M−1.8M (−34%)8 of 8
3
INSM
Insmed Inc
$50.6M7.5%444K+30K (+7%)8 of 8
4
ACAD
Acadia Pharmaceuticals Inc
$50.1M7.5%2.5M−378K (−13%)8 of 8
5
BMRN
Biomarin Pharmaceutical Inc
$38.5M5.7%642K−40K (−6%)8 of 8
6
MIRM
Mirum Pharmaceuticals Inc
$33.1M4.9%387K+39K (+11%)8 of 8
7
UTHR
United Therapeutics Corp Del
$31.9M4.8%59K−3,712 (−6%)8 of 8
8
DYN
Dyne Therapeutics Inc
$30.3M4.5%1.9M+234K (+14%)7 of 8
9
BIIB
Biogen Inc
$30M4.5%133K−7,361 (−5%)8 of 8
10
ANAB
Anaptysbio Inc
$29.9M4.5%595K−8,225 (−1%)8 of 8
🔒 46 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Reported value

last 8 quarters
$645MQ4 '24
$525MQ1 '25
$470MQ2 '25
$540MQ3 '25
$718MQ4 '25
$654MQ1 '26
$724MQ2 '26
$672MQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 16, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Palo Alto Investors 13F FAQ

What does Palo Alto Investors own?

Palo Alto Investors reported 56 stocks worth $672M in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are PTCT (8.4%), IOVA (7.7%) and INSM (7.5%). The table above lists every position in the filing (the top 10 without an account).

What did Palo Alto Investors buy and sell in Q3 2026?

Compared with Q2 2026: 4 new positions, 10 added to, 25 trimmed and 0 sold out. New positions include TARA, CTNM and ANL.

When will Palo Alto Investors file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is Palo Alto Investors's portfolio worth?

The Q3 2026 filing reports $672M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.